← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 enGene Therapeutics ENGN $105M	60	-2	-3%	$86.5M
102	102 TScan Therapeutics TCRX $14.3M	60	0	0%	$35.1M
103	103 Adicet Bio ACET $45.8M	56	+7	+14%	$52.8M
104	104 Fortress Biotech FBIO $63.4M	55	+3	+6%	$17.7M
105	105 Coya Therapeutics COYA $98.1M	54	-2	-4%	$45.5M
106	106 Global X Genomics & Biotechnology ETF GNOM $97.9M	48	+8	+20%	$27.4M
107	GRML 107 Greenland Mines Ltd GRML $86.6M	47	+22	+88%	$4.97M
108	108 Metagenomi Therapeutics MGX $32.5M	43	-5	-10%	$7.45M
109	109 Celularity CELU $42.5M	39	+1	+3%	$2.44M
110	LGVN 110 Longeveron LGVN $5.52M	39	+9	+30%	$3.35M
111	111 Atara Biotherapeutics ATRA $96M	36	+3	+9%	$51.3M
112	112 Marker Therapeutics MRKR $14.8M	35	0	0%	$5.84M
113	113 Bionano Genomics BNGO $16.1M	34	+2	+6%	$802K
114	114 Passage Bio PASG $11.8M	29	-6	-17%	$6.82M
115	115 PharmaCyte Biotech PMCB $3.74M	28	-4	-13%	$586K
116	116 Cellectis CLLS $113M	27	-5	-16%	$28.4M
117	117 MiNK Therapeutics INKT $52.8M	27	+4	+17%	$2.39M
118	118 Instil Bio TIL $40.4M	26	-6	-19%	$29.2M
119	119 Enlivex Ltd ENLV $4.29M	24	-10	-29%	$2.34M
120	120 Imunon IMNN $5.84M	23	+4	+21%	$754K
121	121 Mustang Bio MBIO $2.8M	23	+1	+5%	$378K
122	122 Calidi Biotherapeutics CLDI $2.26M	22	-5	-19%	$89.3K
123	123 BioCardia BCDA $14M	21	+3	+17%	$1.65M
124	124 IN8bio INAB $11.8M	21	+2	+11%	$5.35M
125	125 Senti Biosciences Holdings SNTI $7.5M	20	+4	+25%	$6.37M